Abstract:p53-induced apoptosis plays a pivotal role in the suppression of tumorigenesis, and mutations in p53 have been found in more than 50% of human tumors. By comparing the proteome of a human colorectal cancer cell transfected with inducible p53 (DLD-1.p53) with that of the control DLD-1 cell line using amino acid-coded mass tagging (AACT)-assisted mass spectrometry, we have broadly identified proteins that are upregulated at the execution stage of the p53-mediated apoptosis. In cell culturing, the deuterium-labeled ( heavy) amino acids were incorporated into the proteome of the induced DLD-1. p53 cells, whereas the DLD-1. vector cells were grown in the unlabeled medium. In high-throughput LC-ESI-MS/MS analyses, the AACT-containing peptides were paired with their unlabeled counterparts, and their relative spectral intensities, reflecting the differential protein expression, were quantified. In addition, our novel AACT-MS method utilized a number of different heavy amino acids as internal markers that significantly increased the peptide sequence coverage for both quantitation and identification purposes. As a result, we were able to identify differentially regulated protein isozymes that would be difficult to distinguish by ICAT-MS methods and to obtain a large dataset of the proteins with altered expression in the late stage of p53-induced apoptosis. The regulated proteins we identified are associated with several distinct functional categories: cell cycle arrest and p53 binding, protein chaperoning, plasma membrane dynamics, stress response, antioxidant enzymes, and anaerobic glycolysis. This result suggests that the p53-induced apoptosis involves the systematic activation of multiple pathways that are glycolysis-relevant, energy-dependent, oxidative stress-mediated, and possibly mediated through interorganelle crosstalks.

Histone Methyltransferase SETD2 in Regulation of P53-mediated Apoptosis

Histone methyltransferase protein SETD2 interacts with p53 and selectively regulates its downstream genes

SETD3 is a positive regulator of DNA-damage-induced apoptosis

Setd2, A H3k36 Lysine Methyltransferase, is Essential for Adult Normal Hematopoiesis and Leukemia Stem Cells

Histone Methyltransferase SETDB1 Regulates Liver Cancer Cell Growth Through Methylation of P53

Methyltransferase Set7/9 regulates p53 activity by interacting with Sirtuin 1 (SIRT1)

Molecular Basis for Oncohistone H3 Recognition by SETD2 Methyltransferase

The methyltransferase Set7/9 (Setd7) is dispensable for the p53-mediated DNA damage response in vivo

The role of human ADA2a in the regulation of p53 acetylation and stability

MST1 Promotes Apoptosis Through Regulating Sirt1-dependent P53 Deacetylation*

Ser46 phosphorylation regulates p53-dependent apoptosis and replicative senescence.

Global Investigation of p53-induced Apoptosis Through Quantitative Proteomic Profiling Using Comparative Amino Acid-coded Tagging

Deacetylation of P53 Modulates Its Effect on Cell Growth and Apoptosis

Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer

Stabilization of SETD3 by deubiquitinase USP27 enhances cell proliferation and hepatocellular carcinoma progression

Mitogen-Activated Protein Kinase Phosphatase 2 : A Novel Transcription Target of P 53 in Apoptosis

Histone methyltransferase SETD2: An epigenetic driver in clear cell renal cell carcinoma

SETDB1-mediated CD147-K71 di-methylation promotes cell apoptosis in non-small cell lung cancer

Mitofusin-2 is a Novel Direct Target of P53.

SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens

E2F1 Regulates P53r2 Gene Expression in P53-Deficient Cells